MCRAE ROBERT CURTIS enters PALISADE BIO, INC. with 240.00 shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives

MCRAE ROBERT CURTIS

Filed: 2/15/2023ACC: 0001493152-23-005220

InsiderMCRAE ROBERT CURTISCIK 1965845

→

IssuerPALISADE BIO, INC.CIK 1357459

Officer· Chief Operating Officer

Since Feb 2023

240.00

Baseline shares

100% direct

240.00

Direct ownership

1 position

57.40K

Derivative underlying

7 instruments

Security positions

All direct

Non-Derivative Holdings1

Common Stock

Direct

Shares owned240.00

Total

240.00 direct240.00

Security Title	Shares Owned	Ownership Type
Common Stock	240.00	Direct
Total	240.00	240.00 direct

Derivative Holdings7

Common Stock Purchase Option

Direct

Underlying security

Common Stock

Underlying shares

12K

Shares owned

N/A

Exercise price

2.40

Expiration

—

Exercise window

—

Restricted Stock Units

Direct

Underlying security

Common Stock

Underlying shares

Shares owned

N/A

Exercise price

0.00

Expiration

—

Exercise window

—

Common Stock Purchase Option

Direct

Underlying security

Common Stock

Underlying shares

1.80K

Shares owned

N/A

Exercise price

52.50

Expiration

—

Exercise window

—

Restricted Stock Units

Direct

Underlying security

Common Stock

Underlying shares

2.62K

Shares owned

N/A

Exercise price

0.00

Expiration

—

Exercise window

—

Restricted Performance Stock Units

Direct

Underlying security

Common Stock

Underlying shares

32.50K

Shares owned

N/A

Exercise price

0.00

Expiration

—

Exercise window

—

Series 1 Common Stock Purchase warrant

Direct

Underlying security

Common Stock

Underlying shares

240.00

Shares owned

N/A

Exercise price

2.38

Expiration

—

Exercise window

—

Series 2 Common Stock Purchase Warrant

Direct

Underlying security

Common Stock

Underlying shares

240.00

Shares owned

N/A

Exercise price

2.38

Expiration

—

Exercise window

—

Total

Underlying

57.40K

Owned

0.00

Security	Underlying	Exercise Price	Exercise Window	Expiration	Underlying Shares	Shares Owned
Common Stock Purchase Option Direct	Common Stock	2.40	—	—	12K	N/A
Restricted Stock Units Direct	Common Stock	0.00	—	—	8K	N/A
Common Stock Purchase Option Direct	Common Stock	52.50	—	—	1.80K	N/A
Restricted Stock Units Direct	Common Stock	0.00	—	—	2.62K	N/A
Restricted Performance Stock Units Direct	Common Stock	0.00	—	—	32.50K	N/A
Series 1 Common Stock Purchase warrant Direct	Common Stock	2.38	—	—	240.00	N/A
Series 2 Common Stock Purchase Warrant Direct	Common Stock	2.38	—	—	240.00	N/A
Total					57.40K	0.00